Studies on Chemotherapeutics for Dermatomycosis. IX
نویسندگان
چکیده
منابع مشابه
Review on dermatomycosis: pathogenesis and treatment
Dermatophytes, a group of keratinophilic fungi thriving on the keratin substrate are the etiological agents responsible for causing cutaneous infections. Dermatophytosis is currently treated with the commercially available topical and oral antifungal agents in spite of the existing side effects. Treatment of these cutaneous infections with secondary metabolites produced by marine microorganisms...
متن کاملStudies on the Relationship of Dermatomycosis to Ulceration and Gangrene of the Extremities *
Ulceration of the legs and gangrene of the feet, common disorders encountered in surgical clinics, are major medical and economic problems since knowledge of their cause is lacking, treatment is highly unsatisfactory, and prevention is impossible. These conditions have been assigned descriptive names based on fairly wellknown natural courses. The ulcers are called "post-phlebitic,"38 39 sometim...
متن کاملDermatomycosis Frequency and Localization Sites
INTRODUCTION Since the prevalence of skin mycotic infections is changing and is area depended we aimed to analyze the frequency of the skin myocotic infections and the appearance sites. MATERIAL AND METHODS There were involved 560 patients referred to the Dermatology Clinic of University Clinical Center of Kosova during a period of one year. RESULTS The mean age of our study group was aroun...
متن کاملTime-resolved fluorescence studies on protoporphyrin IX-apohorseradish peroxidase.
The hemin moiety of horseradish peroxidase (donor:hydrogen-peroxide oxidoreductase, EC 1.11.1.7) was removed and the apoprotein reconstituted with the fluorescent protoporphyrin IX. Steady-state and time-resolved fluorescence properties of the HRP(desFe) adduct were examined; the multifrequency phase and modulation method was utilized for lifetime and dynamic polarization studies. The emission ...
متن کاملAntifungal chemotherapeutics.
This review addresses trends in outcome and risk factors for invasive fungal infections, current antifungal agents and new therapeutic strategies. Current prospects for new therapies rest upon caspofungin, the first of a new class of antifungal molecules, the echinocandins, and new extended-spectrum azoles, voriconazole, posaconazole and ravuconazole. Approval by the Food and Drug Administratio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 1953
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi1947.73.8_818